The last decade has witnessed a rapid development of
nano- and
microparticle-based optical ion sensors, including ion-selective optodes
(ISOs). While the application of nano-ISOs has shown promising performance
for sensing inorganic ions, polyion sensing using nanoscale ISOs has
encountered significant interference in complex samples such as blood
plasma. Recently, we have reported on a new polyion sensing principle
that operates through a novel mechanism to overcome this challenge.
The new sensing mechanism showed improved characteristics not observed
with conventional ion-exchange type sensors, but the precise mechanism
of operation remained thus far unclear. This paper aims to clarify
how protamine, the arginine-rich target polycation, behaves during
optical signal transduction to give dramatically improved selectivity.
Based on thermodynamic data, sensor performance and ζ-potential
analysis, two discrete phases of protamine extraction are identified.
Initially, protamine extracts into the bulk nanosensor phase, a process
that is concurrent with the optical signal change. This is then followed
by protamine accumulation onto the nanosensor surface, which starts
only upon saturation of the optical signal change. The data indicate
that the improved selectivity is due to the inability of small ions
to form a sufficiently strong interaction with an active sensing ingredient,
DNNS–. Any exchange of one inorganic cation for
another therefore remains optically silent, suppressing matrix effects.
Moreover, the recognition of protamine is shown to be an exhaustive
extraction process, making the response independent of the nature
and concentration of the initial small cation in the nanosensor phase.